key: cord-0261300-0ld0k1gt
authors: Te, Nigeer; Rodon, Jordi; Ballester, Maria; Pérez, Mónica; Pailler-García, Lola; Segalés, Joaquim; Vergara-Alert, Júlia; Bensaid, Albert
title: Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are key features of alpacas resolving MERS-CoV infection
date: 2020-11-24
journal: bioRxiv
DOI: 10.1101/2020.11.23.395301
sha: 79c38cccc9063b49f461dd0f4aef29b7458d09fc
doc_id: 261300
cord_uid: 0ld0k1gt

While MERS-CoV (Middle East respiratory syndrome Coronavirus) provokes a lethal disease in humans, camelids, the main virus reservoir, are asymptomatic carriers, suggesting a crucial role for innate immune responses in controlling the infection. Experimentally infected camelids clear infectious virus within one week and mount an effective adaptive immune response. Here, transcription of immune response genes was monitored in the respiratory tract of MERS-CoV infected alpacas. Concomitant to the peak of infection, occurring at 2 days post inoculation (dpi), type I and III interferons (IFNs) were maximally transcribed only in the nasal mucosa of alpacas, provoking the induction of interferon stimulated genes (ISGs) along the whole respiratory tract. Simultaneous to mild focal infiltration of leukocytes in nasal mucosa and submucosa, upregulation of the anti-inflammatory cytokine IL10 and dampened transcription of pro-inflammatory genes under NF-κB control were observed. In the lung, early (1 dpi) transcription of chemokines (CCL2 and CCL3) correlated with a transient accumulation of mainly mononuclear leukocytes. A tight regulation of IFNs in lungs with expression of ISGs and controlled inflammatory responses, might contribute to virus clearance without causing tissue damage. Thus, the nasal mucosa, the main target of MERS-CoV in camelids, is central in driving an efficient innate immune response based on triggering ISGs as well as the dual anti-inflammatory effects of type III IFNs and IL10. IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) is the etiological agent of a respiratory disease causing high mortality in humans. In camelids, the main MERS-CoV reservoir host, viral infection leads to subclinical disease. Our study describes transcriptional regulations of innate immunological pathways underlying asymptomatic clinical manifestations of alpacas in response to MERS-CoV. Concomitant to the peak of infection, these animals elicited a strong transient interferon response and induction of the anti-inflammatory cytokine IL10 in the nasal mucosa. This was associated to a dimmed regulation of pro-inflammatory cytokines and induction of interferon stimulated genes along the whole respiratory mucosa, leading to the rapid clearance of the virus. Thus, innate immune responses occurring in the nasal mucosa appear to be the key in controlling MERS-CoV disease by avoiding a cytokine storm. Understanding on how asymptomatic host reservoirs counteract MERS-CoV infection will aid in the development of antiviral drugs and vaccines.

asymptomatic, leading to a rapid clearance of the virus (5, 9, 11) and the establishment 63 of a solid acquired immunity. Indeed, field studies revealed a high proportion of serum 64 neutralizing antibodies in dromedary camels (8, 12) . Innate immune responses are 65 essential as they link adaptive immunity (13) and are key players in the pathology of 66 diseases (14). Nevertheless, the severity of MERS lesions in humans has been attributed 67 to aberrant innate and adaptive immune responses based essentially on data obtained 68 from macrophages isolated from healthy donors or infected patients, as well as dosage 69 of cytokines/chemokines from bronchoalveolar lavages. The outcome of these studies 70 reveals an overproduction of proinflammatory cytokines/chemokines due to the 71 activation of C-type lectin receptors, RIG-I like receptors (RLRs) and an impaired 72 production of type I interferons (IFN) (15) (16) (17) (18) . High production and persistent high 73 12 upregulated. Indeed, IL8 was downregulated (mean of -40 Fc). According to these 273 findings, the anti-inflammatory cytokine IL10 (mean of 3.5 Fc) was moderately 274 upregulated (Fig. 4A , B and Data set S1D). Furthermore, the submucosa underlying 275 epithelial cells with no MERS-CoV IHC labelling showed the same patterns of cytokine 276 profiles as for that underlying heavily MERS-CoV infected mucosa but to a lesser 277 degree of expression ( Fig. 4A and B) . Overall, results obtained in the submucosa are 278 indicative of a potential IFN paracrine signaling from the epithelium for the occurrence 279 of ISGs induction in the absence of significant IFN mRNA synthesis. Moreover, despite 280 mild focal infiltrations (Fig. 2) , genes involved in the inflammatory process were either 281 suppressed, unaltered or mildly activated. 282

ISGs are upregulated in the trachea of infected alpacas without increased 283 endogenous IFNs mRNA 284

Innate immune response genes were further monitored along the URT. In trachea, IFNβ 285 and IFNλ3 mRNA transcripts were not detected at any time post-inoculation including 286 on 0 dpi. From 1 to 4 dpi, expression of IFNα and λ1 was slightly downregulated or 287 unaltered, compared to basal levels found in non-infected controls ( Fig. 5A and Data set 288 S1E). Genes coding for ISGs (ISG15, MX1 and OAS1) and PRRs (RIG1, MDA5 and 289 TLR3) showed a significant mRNA upregulation mainly at 2 and 3 dpi. When 290 compared with animals necropsied at 1 dpi, IRF7 was significantly upregulated (mean 291 of 9 Fc) at 2 dpi ( Fig. 5A and B ). The expression of IL10 was not significantly altered 292 and Data set S1E). Excluding OAS1, AP6 was the animal with the highest expression 298 levels of ISGs, RNA sensors, transcriptional factors and chemokines as shown in Fig.  299 5A, B, D, Fig. S3B and Data set S1E. In that respect, AP6 could be considered as an out 300 layer since, unlike other animals, it presented nasal discharges with the highest number 301 of infected cells in nose and trachea and the highest viral loads in trachea (Table S1 and 302 Data set S1A). Moreover, when compared to AP4 and AP5, which displayed nearly 303 basal levels of CCL2 and CCL3 transcripts (Fig. 5C, Fig. S5A and Data set S1E), the 304 tracheal submucosa of AP6 was moderately infiltrated by macrophages and 305 lymphocytes (Fig. 5D ). This also provides indirect proof that the chemokines CCL2 and 306 CCL3 were produced at the protein level and exerted chemoattraction. 307

Despite low infectivity of MERS-CoV in the LRT, infiltration of leukocytes was 310 observed suggesting that cytokines and chemokines are at play. At the lung level, IFNα 311 and IFNλ1 were expressed on 0 dpi in non-infected controls. In response to MERS-CoV, 312 transcripts of IFNα and IFNλ1 fluctuated around basal levels ( Fig. 6A and Data set S1F). 313

IFNλ3 and IFNβ mRNAs were not detected in any of the animals including controls. 314

Upregulation of ISGs (ISG15, MX1 and OAS1) and IRF7 started at 1 dpi, reached a 315 peak at 2 dpi and weaned at 4 dpi. RIG1 and MDA5 were unevenly upregulated with a 316 lower intensity than for other tissues ( Fig. S3C and Data set S1F). Remarkably, NLRP3 317 was moderately but significantly upregulated at 1, 2 and 4 dpi concomitant with 318 increased levels of TNFα and IL1β at 1 dpi ( Fig. 6A and B) . However, transcription of 319 CASP1 remained unaltered and the PYCARD gene was downregulated at 1, 2 and 4 dpi 320 or unaltered at 3 dpi ( Fig. S3C and Data set S1F). IL15, a natural killer cell activator 321 cytokine, was significantly upregulated at 1 and 2 dpi while expression patterns of other 322 14 proinflammatory cytokines varied between animals and days of infection ( Fig. 6A and  323 B, Fig. S3C and Data set S1F). 324

In addition, CCL2 and CCL3 were moderately to highly upregulated at most of the time 325 points (Fig. 7A, Fig. S3C and Fig. S5B ). All animals showed very mild infiltration of 326 leukocytes in the alveoli in response to MERS-CoV ( Fig. 7B and Fig. S5C ). 327

Remarkably, AP6 showed accumulation of leukocytes without a noTable induction of 328 CCL2 and CCL3 mRNAs. Moreover, this animal was the highest producer of these 329 Transcription of the NF-κB p50 subunit (NFKB1) and some important regulators of the 340 NF-κB pathway were checked along URTs and LRTs. These regulators included two 341 enzymes, AZI2 and TBK1, downstream of the RLRs and TLR signaling pathways, 342 essential for the phosphorylation of NF-κB, the NF-κB inhibitor NFKBIA and an 343 adaptor CARD9 that mediates signals from C-type lectins to regulate the NF-κB 344 pathway (Fig. S6 ). All these genes were expressed at basal levels in the nasal mucosa, 345 submucosa, trachea and lung of control non-infected alpacas. NFKB1, AZI2 and TBK1 346 were only marginally induced or remained unaltered in the nasal epithelia; however, 347 15 NFKBIA and CARD9 were expressed at basal levels or even slightly downregulated in 348 all the tissues. All the above mentioned genes were fluctuating around basal 349 transcriptional levels across alpaca respiratory tracts ( Fig. 3A-6A and Data set S1 C-F) 350

indicating that the NF-κB mediated signaling pathway was not exacerbated or 351 downregulated in response to MERS-CoV. Moreover, IRF5, an inducer of TNF and 352 IL6 as well as an important factor for the polarization of M1 macrophages, was only 353 slightly but significantly upregulated in the nasal epithelium (2 dpi) and submucosa (3 354 dpi). In all other tissues and, in particular lung, the majority of animals did not reach the 355 threshold of 2 Fc for IRF5 ( Fig. S3C and Data set S1F). In mucosa, pathogens are sensed by PRRs leading to the production of type I and III 377

IFNs via IRFs. In turn, IFNs can activate through the JAK-STAT pathway, in an 378 autocrine, paracrine or endocrine manner, transcription of various antiviral and 379 regulatory ISGs including also PRRs and IRFs. Fine tuning of these responses is 380 paramount in determining the outcome of viral infectious diseases (31). In MERS-CoV 381 infected alpacas, during the first 24h, apart from IFNβ which started to be induced, type 382 I and III IFNs were not altered in the nasal mucosa when compared to control animals. 383

This short period seems to be crucial for the virus to establish a productive infection in 384 alpacas for at least 5 to 6 days (5) by delaying host protective mechanisms such as 385 activation of PRR pathways (17, 30, 35) . Nonetheless, and only in the nasal epithelium, 386 transcription of all type I and III IFNs peaked simultaneously at 2 dpi and weaned 387

progressively. This wave of IFNs was concomitant with the induction of ISGs, PRRs 388 and IRF7 not only at the nasal epithelial barrier and its underlying submucosa but also 389 in trachea and lungs where IFN mRNAs were never detected or induced. Therefore, the 390 effect of the IFN response at the nasal mucosa may extend to distant respiratory tissues 391 in a paracrine or endocrine manner. In that respect, in mice, IFN produced in the URT 392 prevents dissemination of influenza virus to the lung (36). 393

The use of IHC and microfluidic PCR assays combined with LCM permitted to 394 compare, in the same and different animals, areas of the nasal epithelium with high and 395 low viral loads. Heavily infected mucosal areas were responsible for the highest 396 induction of type III IFNs. Although markedly induced, type I IFNs did not 397 17 significantly correlated with tissue viral loads. Consistent with this IFN production, the 398 number of MERS-CoV infected cells detected by IHC was maximal on 2 dpi and 399 decreased over time. However, all infected alpacas shed infectious viral particles in the 400 nasal cavity from 1 dpi onwards according to previous studies (5, 6). This might be due 401 to a high accumulation of virus in the nasal cavity which may take a few days to clear. 402

Remarkably, results obtained herein contrast with those found in human epithelial cells 403 and respiratory explants since the induction of type I and III IFNs was limited or 404 inhibited in response to 20, 23 

For each animal, four consecutive sections from the same MFPE-block containing nasal 501 specimens were cut and processed as described in the supplementary material and 502 method section. One of the sections was subjected to IHC to localize infected/non 503 infected cells in the tissues and served as a reference (template) for the three subsequent 504 sections which were subjected to LCM. Infected and non-infected nasal epithelium 505 (mucosa) areas, as assessed by IHC in the template section, as well as their respective 506 underlying submucosa areas were delineated and micro-dissected using the Leica 507 LMD6500 (Leica AS LMD; Wetzlar, Germany) system (6.3× magnification, Laser 508

Microdissection 6500 software version 6.7.0.3754). More detailed information is 509 provided in Fig. S1 for visualization of the microdissection process. 510

Dissected specific areas from each three MFPE sections were measured and introduced 511 into RNase-free 0.5 ml Eppendorf tubes with buffer PKD from the miRNeasy FFPE Kit 512 (Qiagen, Valencia, CA, USA). Direct microdissection of IHC stained MFPE sections 513 were attempted but failed to provide RNA with enough quality and yields for further 514 microfluidic quantitative PCR assays. 515

Total RNA extraction from micro-dissected or scraped tissues was performed using the 517 miRNeasy FFPE Kit, following the manufacturer's instruction. Isolated RNA was 518 concentrated by precipitation in ethanol, purified using RNeasy MinElute spin columns 519 (Qiagen, Hilden, Germany) and treated for 10 min with DNase I (ArcticZymes, 520 Norway). cDNA was generated from 110 ng of total RNA using the PrimeScript™ RT 521 reagent Kit (Takara, Japan) with a combination of both oligo-dT and random hexamers 522 22 following manufacturer's instructions. Additionally, total RNA extracts from MERS-523

CoV infected nasal epithelia of AP5, 6, 7, 8, 9 and 11 were pooled at the same 524 proportion per animal and used to generate cDNA controls for validation of gene 525 expression assays. 526

Thirty-seven innate immune genes were selected to study the gene expression and 529 transcriptional regulation of the main known canonical signaling pathways acting on 530 antiviral innate immunity and inflammation (Fig. S6) . Primer design and validation for 531 an efficient cDNA amplification (Table S2) is described in detail in the Text S1 section 532 (Text S1). cDNA from micro-dissected or scraped tissue samples were used to quantify 533 camelid gene expression levels in duplicates by a microfluidic qPCR with the 96.96 534 Dynamic Array integrated fluidic circuit of the Biomark HD system (Fluidigm 535

Corporation, South San Francisco, USA), according to the manufacturer's instructions 536 (see Text S1). 537

Data analyses and normalization of microfluidic qPCR assays is described in the Text 539 S1 section. Briefly, the relative standard curve method (see Applied Biosystems User 540 Bulletin #2 541 https://www.gu.se/digitalAssets/1125/1125331_ABI__Guide_Relative_Quantification_ 542 using_realtime_PCR.pdf) was applied to extrapolate the quantity values of targets and 543 normalizer genes of the studied samples. Then, the target amount is normalized by using 544 the combination of three reference control genes. The normalized quantity (NQ) values 545 of individual samples from infected animals at different dpi were used for comparison 546 against the NQ mean of three non-infected control animals (calibrator) per assay. Thus, 547 23 the up-or down-regulated expression of each gene was expressed in fold changes (Fc) 548 after dividing each individual NQ value with the calibrator. Unlike all other tested 549 genes, IFNβ mRNA was undetecTable in the nasal epithelia of non-infected control 550 animals, therefore, comparisons for this gene in the nasal epithelia were performed in 551 relation to the mean of IFNβ levels of three infected alpacas on 1 dpi. Data set S1C-F 552 recompiles all the results expressed in Fc relative to the control alpacas obtained with 553 the Fluidigm microfluidic assay for all 37 genes tested. Data set S1A shows the 554 quantification, expressed in Cq values, of MERS-CoV genomic (UpE) and subgenomic 555 RNA (M mRNA), obtained with the microfluidic qPCR assay. Data set S1B indicates 556 the expression levels (in Cq values) of all genes from non-infected alpacas euthanized at 557 0 dpi. The limit of detection for expressed genes was Cq=25. A logarithmic 10 558 transformations were applied on Fc values to approach a log normal distribution. Thus, 559 the Student's t-test could be used to compare the means of the logarithmic Fc obtained 560 at different dpi for each group of animals. Significant upregulation or downregulation of 561 genes was considered if they met the criteria of a relative Fc of ≥2-fold or ≤2-fold 562 respectively with P < 0.05. Having determined that RT-qPCR data ( The nasal epithelium of each alpaca (AP1 to AP15) was micro-dissected, as assessed by IHC (see the image of the nasal turbinate section in the upper right). Infected (orange)/noninfected (green) areas were isolated by LCM for RNA extraction and conversion to cDNA. The Fluidigm Biomark microfluidic assay was used to quantify transcripts of innate immune genes at different dpi. After normalization, Fc values between controls and infected animals were calculated. The resulting heatmap shows color variations corresponding to log2 Fc values; blue for increased and red for decreased gene expression values of infected animals compared to control animals, respectively. IFNβ was normalized with 1 dpi samples because it was not detected at 0 dpi. Grey rectangles indicate no detection of the corresponding gene. TFs, transcription factors; CKs, chemokines; ADs, adaptors; RT, receptor. MERS-CoV+ and MERS-CoV-, MERS-CoV positive and negative epithelium areas as assessed by IHC, respectively. (B) Average Fc of IFNs, ISGs, PRRs, IRF7, IL10 and TRIM25 genes in MERS-CoV+ nasal epithelia (white bars) and MERS-CoV-nasal epithelia (black bars) as assessed by IHC. Data are shown as means of ±SD. Statistical significance was determined by Student's t-test. *P < 0.05; **P < 0.01; ***P < 0.001 when compared with the average values of non-infected alpacas (n = 3); #P < 0.05; ##P < 0.01; ###P < 0.001 when comparisons between groups are performed at different dpi. , 2, 3, 7, 8, 9, 13, 14 and 15 ) was microdissected and areas underlying infected (orange)/non-infected (green) epithelium, as assessed by IHC (see the right panel), were selected and isolated for RNA extraction and conversion to cDNA. The Fluidigm Biomark microfluidic assay was used to quantify transcripts of innate immune genes at different dpi. After normalization, Fc values between controls and infected animals were calculated. The resulting heatmap shows color variations corresponding to log2 Fc values; blue for increased and red for decreased gene expression, respectively. The grey rectangles indicate no detection of the corresponding gene. TFs, transcription factors; CKs, chemokines; ADs, adaptors; RT, receptor. MERS-CoV+ and MERS-CoV-, MERS-CoV positive and negative epithelium areas as assessed by IHC, respectively. (B) Average Fc of ISGs, PRRs, IRF7, IL10, IL1β, IL8, NLRP3, CASP1and PYCARD genes in the submucosa underneath IHC MERS-CoV+ nasal epithelium (white bars) and IHC MERS-CoV-nasal epithelium (black bars). Data are shown as means of ±SD. Statistical significance was determined by Student's t-test. *P < 0.05; **P < 0.01; ***P < 0.001 when compared with the average values of non-infected alpacas (n = 3); #P < 0.05; ##P < 0.01; ###P < 0.001 when comparisons between groups are performed at different dpi. infected alpacas (AP1-12), followed by RNA extraction and conversion to cDNA. A Fluidigm Biomark microfluidic assay was used to quantify transcripts of innate immune genes at different dpi. After normalization, Fc values between controls and infected animals were calculated. The resulting heatmap shows color variations corresponding to log2 Fc values; blue for increased and red for decreased gene expression, respectively. The grey rectangles indicate no detection of the corresponding gene. TFs, transcription factors; CKs, chemokines; ADs, adaptors; RT, receptor. (B) Average fold changes of ISGs, PRRs, IL8, IL1β and IRF7 genes in trachea. Data are shown as means of ±SD. Statistical significance was determined by Student's t-test. *P < 0.05; **P < 0.01; ***P < 0.001 (n = 3) when compared with noninfected alpacas (n = 3). (C) On 2 dpi, no inflammatory cells were observed in the tracheal submucosa of AP4 (see H/E stained MFPE tracheal section at the left). The graph at the right depicts Fc of mRNA transcripts for CCL2 and CCL3 in relation to control animals. (D) Infiltration of monocytes and lymphocytes in the tracheal submucosa of AP6 (see H/E stained MFPE tracheal section at the left) was associated with increased mRNA transcripts of CCL2 and CCL3 (see the bar graph at the right). The lung sample of each infected alpaca (AP1 to AP15) was isolated for RNA extraction and conversion to cDNA. A Fluidigm Biomark microfluidic assay was used to quantify transcripts of innate immune genes at different dpi. After normalization, Fc values between controls and infected animals were calculated. The resulting heatmap shows color variations corresponding to log2 Fc values; blue for increased and red for decreased gene expression, respectively. The grey rectangles indicate no expression of the corresponding gene. TFs, transcription factors; CKs, chemokines; ADs, adaptors; RT, receptor. (B) Bar graphs representing average mRNA fold changes of ISGs (ISG15, MX1, CXCL10 and OAS1), IRF7, NLRP3, the inflammatory cytokines IL1β, TNFα, IL10 and IL15 genes in lung. Data are shown as means of ±SD. Statistical significance was determined by Student's t-test. *P < 0.05; **P < 0.01; ***P < 0.001 (n = 3) compared with non-infected alpacas (n = 3); #P < 0.05; ##P < 0.01; ###P < 0.001 (n = 3) when comparisons between groups are performed at different dpi.

Replication and shedding of MERS-CoV in upper 606 respiratory tract of inoculated droamedary camels

Middle East respiratory syndrome coronavirus neutralising serum 612 antibodies in dromedary camels: A comparative serological study

Toll-like receptors: Critical proteins linking 615 innate and acquired immunity

Basic Mechanisms to Translational Medicine

MERS-CoV 621 infection is associated with downregulation of genes encoding Th1 and Th2

cytokines/chemokines and elevated inflammatory innate immune response in the 623 lower respiratory tract

Active replication of middle east respiratory syndrome coronavirus and 627 aberrant induction of inflammatory cytokines and chemokines in human 628 macrophages: Implications for pathogenesis

Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to 632

Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-633

Infected Macrophages

Efficient replication of the novel human betacoronavirus EMC on primary human 637 epithelium highlights its zoonotic potential

Human Cell Tropism and Innate Immune System 640 Interactions of Human Respiratory Coronavirus EMC Compared to Those of 641

Severe Acute Respiratory Syndrome Coronavirus

Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b

Tropism and replication of Middle East respiratory syndrome coronavirus from 648 dromedary camels in the human respiratory tract: An in-vitro and ex-vivo study

MERS coronaviruses 655 from camels in Africa exhibit region-dependent genetic diversity

Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus 660 in Human Ex Vivo Respiratory Organ Cultures

Middle East Respiratory Syndrome 663

Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist

The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle

East respiratory syndrome coronavirus (MERS-CoV) are potent interferon 668 antagonists

The authors declare that they have no competing interests. 795 

Text S1 915 Fc±SD. Statistical significance was determined by Student's ttest. *P < 0.05; **P < 961 0.01; ***P < 0.001 (n = 3) when compared with the average values of non-infected 962 alpacas (n = 3); #P < 0.05; ##P < 0.01; ###P < 0.001 (n = 3) when comparisons 963 between groups are performed at different dpi. Significant upregulation of genes was 964 considered if they met the criteria of a relative fold change of ≥2-fold with P < 0.05; 965 similarly, significant downregulation of genes was considered if they met the criteria of 966 a relative fold change of ≤2-fold with P < 0.05. 967 lectins signaling and upstream of the NF-κB pathway) are not represented in the 1018 diagram but were assayed for transcriptional regulation. Gene products, depicted with 1019 42 frames and colors were selected for microfluidic PCR assays, on basis of 1020 bibliographical data showing that they can be transcriptionally regulated following 1021 infection by RNA viruses. Furthermore, the selected genes sample most of the known 1022 signaling pathways triggered during a viral infectious process. P, phosphorylation. 1023 Table S1 . MERS-CoV N protein distribution in alpaca respiratory tracts by 1024 immunohistochemistry. 1025 Table S2 . Sequence and characteristics of primers used for microfluidic qPCR assays in 1026 alpacas. 1027Data set S1. The expression levels of innate immune response genes, and viral loads 1028 A and B) . Each bar represents the mean Cq value +SD of infected tissues from 3 animals euthanized on 0, 1, 2, 3 and 4 dpi, respectively (in total 15 animals). Statistical significance was determined by Tukey's multiple comparisons test. *P < 0.05; **P < 0.01; ***P < 0.001. Dashed lines depict the detection limit of the assays. Cq, quantification cycle; TCID50, 50% tissue culture infective dose. PRRs and IRFs are engaged to induce IFNs and ISGs exerting their effects in an autocrine or paracrine manner. Upregulation of IL10 combined with the action of type III IFNs will result in a dimmed synthesis of proinflammatory cytokines under NF-κB control. Induced chemokines lead to focal, mild infiltration of leukocytes. The paracrine effect of IFNs is evidenced in the nasal submucosa where ISGs are upregulated without endogenous induction of IFNs. IL10 and type III IFNs will act on the NF-κB pathway preventing production of IL8 and IL1β mRNAs depriving the NLRP3 inflammasome of its substrate. Slight increased levels of IRF5 mRNAs will indicate the presence of few M1 macrophages in the submucosa. Blue, red and white arrows indicate upregulation, downregulation and unaltered gene transcription respectively. (B) Concomitant to decreased viral loads, transcription of ISGs is lowered in trachea and lungs where IFNs are not induced. Infiltration of mainly mononuclear leukocytes occurs in the lungs as a result of chemokine synthesis in the absence of IRF5 induction but upregulation of IL15. Thus, reduced number of M1 macrophages and activation of NK cells will contribute to a controlled inflammation and clearance of the virus. PI, Pro-inflammatory cytokines; NI, not induced.